Quinapril

In the US, Quinapril (quinapril systemic) is a member of the drug class angiotensin converting enzyme inhibitors and is used to treat Diabetic Kidney Disease, Heart Failure, High Blood Pressure and Left Ventricular Dysfunction.

US matches:

• Quinapril


• Quinapril/Hydrochlorothiazide


• Quinapril and hydrochlorothiazide


• Quinapril Hydrochloride


• Quinapril Hydrochloride/Hydrochlorothiazide

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

C09AA06

CAS registry number (Chemical Abstracts Service)

0085441-61-8

Chemical Formula

C25-H30-N2-O5

Molecular Weight

438

Therapeutic Categories

Antihypertensive agent

ACE inhibitor

Chemical Name

3-Isoquinolinecarboxylic acid, 2-[2-[[1-(ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]-1,2,3,4-tetrahydro-, [3S-[2[R*(R*)],3R*]]-

Foreign Names

• Quinaprilum (Latin)
• Quinapril (German)
• Quinapril (French)
• Quinapril (Spanish)

Generic Names

• Quinapril (OS: BAN, DCF)
• Asig (IS)
• Kvinapril (IS)
• Quinapril tablets (PH: USP 27)
• Quinapril Hydrochloride (OS: USAN)
• CI 906 (IS: Parke-Davis)
• PD-109452-2 (IS)
• Quinapril hydrochloride (PH: USP 32)

Brand Names

• Accupril
  Pfizer, Peru



• Accupro
  Gödecke, Germany; Gödecke, Poland; Goedecke, Russian Federation; Pfizer, Bulgaria; Pfizer, Germany; Pfizer, Ireland



• Accuretic
  Parke Davis, Ireland



• Accuretic (Quinapril and Hydrochlorothiazide)
  Pfizer, United Kingdom



• Accustad H (Quinapril and Hydrochlorothiazide)
  Stada, Poland



• Accuzide (Quinapril and Hydrochlorothiazide)
  Parke Davis, Poland



• Acczide (Quinapril and Hydrochlorothiazide)
  Pfizer, Oman



• Acenor
  Zifam India, Myanmar



• Aceplus (Quinapril and Hydrochlorothiazide)
  Bristol-Myers Squibb, Italy



• Acuilix (Quinapril and Hydrochlorothiazide)
  Pfizer, Tunisia



• Acuitel
  Parke Davis, Oman; Pfizer, Oman; Pfizer, Tunisia



• Acupril
  Pfizer, Portugal



• Acurenal
  ICN, Poland



• Adco-Quinaretic (Quinapril and Hydrochlorothiazide)
  Adcock Ingram Pharmaceuticals, South Africa



• AprilGen
  Generics, Poland



• Aquril
  Labormed Pharma, Romania



• Co-Quinapril EG (Quinapril and Hydrochlorothiazide)
  Eurogenerics, Luxembourg



• Hemokvin
  Hemofarm, Serbia



• Pulsaren
  Biofarm, Poland



• Q-pril
  Polpharma, Poland



• Quinace Co (Quinapril and Hydrochlorothiazide)
  Pharma Dynamics, South Africa



• Quinapril beta comp (Quinapril and Hydrochlorothiazide)
  Betapharm, Germany



• Quinapril Merck
  Merck Genéricos, Portugal



• Quinapril Sandoz
  Hexal, Romania



• Quinapril Teva
  Teva, Czech Republic; Teva, Lithuania; Teva, Latvia; Teva, Poland; Teva, Slovakia



• Quinapril Winthrop
  Winthrop, Italy



• Quinapril
  Mylan, United States



• Quinapril-EG
  Eurogenerics, Luxembourg



• Quinapril-Ratiopharm
  ratiopharm, Luxembourg



• Quinapro
  Biex, Ireland



• Quiprex
  Heimdall, Colombia



• Quizicor (Quinapril andHydrochlorothiazide)
  Actavis, Bulgaria



• Ranacu
  Ranbaxy, Bulgaria



• Regrace
  Ranbaxy, Poland



• Accupril
  Pfizer, Argentina; Pfizer, Australia; Pfizer, Belgium; Pfizer, Brazil; Pfizer, Belize; Pfizer, Canada; Pfizer, Chile; Pfizer, Colombia; Pfizer, Costa Rica; Pfizer, Ecuador; Pfizer, Guatemala; Pfizer, Hong Kong; Pfizer, Honduras; Pfizer, Indonesia; Pfizer, Luxembourg; Pfizer, Myanmar; Pfizer, Nicaragua; Pfizer, New Zealand; Pfizer, Panama; Pfizer, Philippines; Pfizer, Singapore; Pfizer, El Salvador; Pfizer, Thailand; Pfizer, Taiwan; Pfizer, United States; Pfizer, Venezuela; Pfizer, Vietnam; Pfizer, South Africa



• Accuprin
  Pfizer, Italy



• Accupro
  Pfizer, Austria; Pfizer, Switzerland; Pfizer, Czech Republic; Pfizer, Denmark; Pfizer, Estonia; Pfizer, Finland; Pfizer, United Kingdom; Pfizer, Georgia; Pfizer, Croatia (Hrvatska); Pfizer, Hungary; Pfizer, Lithuania; Pfizer, Latvia; Pfizer, Romania; Pfizer, Sweden; Pfizer, Slovakia



• Accupro Comp (Quinapril and Hydrochlorothiazide)
  Pfizer, Finland; Pfizer, Sweden



• Accupron
  Pfizer, Greece



• Accuretic
  Pfizer, Argentina; Pfizer, United Kingdom



• Accuretic (Quinapril and Hydrochlorothiazide)
  Pfizer, Australia; Pfizer, Belgium; Pfizer, Canada; Pfizer, Switzerland; Pfizer, Colombia; Pfizer, Greece; Pfizer, Italy; Pfizer, Peru; Pfizer, United States; Pfizer, South Africa



• Accuzide
  Pfizer, Bulgaria; Pfizer, Czech Republic; Pfizer, Lithuania



• Accuzide (Quinapril and Hydrochlorothiazide)
  AstraZeneca, Bahrain; Gödecke, Germany; Pfizer, Austria; Pfizer, Germany; Pfizer, Croatia (Hrvatska); Pfizer, Hungary; Pfizer, Slovakia



• Acequide (Quinapril and Hydrochlorothiazide)
  Recordati, Italy



• Acequin
  Recordati, Italy



• Acquin
  Sigma, Australia



• Acuilix (Quinapril and Hydrochlorothiazide)
  Pfizer, France



• Acuitel
  Pfizer, Bahrain; Pfizer, France; Pfizer, Turkey



• Acumerck
  Generics, Hungary



• Acuprel
  Parke Davis, Spain



• Acupril
  Pfizer, Mexico; Pfizer, Netherlands; Pfizer, Peru



• Acuretic
  Pfizer, Portugal



• Acuretic (Quinapril and Hydrochlorothiazide)
  Binesa, Spain



• Acuzide (Quinapril and Hydrochlorothiazide)
  Pfizer, Netherlands



• Apo-Quinapril
  Apotex, Australia



• Bicetil (Quinapril and Hydrochlorothiazide)
  Menarini, Spain



• Conan
  Tanabe Mitsubishi, Japan



• Co-Quinapril EG (Quinapril and Hydrochlorothiazide)
  Eurogenerics, Belgium



• Co-Quinapril Sandoz (Quinapril and Hydrochlorothiazide)
  Sandoz, Belgium



• Ectren
  Menarini, Spain



• Filpril
  Alphapharm, Australia



• Korec
  Sanofi-Aventis, France



• Koretic (Quinapril and Hydrochlorothiazide)
  Sanofi-Aventis, France



• Lidaltrin Diu (Quinapril and Hydrochlorothiazide)
  Lacer, Spain



• Lidaltrin
  Lacer, Spain



• Naprishin
  Towa Yakuhin, Japan



• Quinace
  Pharma Dynamics, South Africa



• Quinagen
  Merck Generics, South Africa



• Quinalar
  Leti, Venezuela



• QuinaLich comp (Quinapril and Hydrochlorothiazide)
  Winthrop, Germany



• Quinaplus AL (Quinapril and Hydrochlorothiazide)
  Aliud, Germany



• Quinaplus Stada (Quinapril and Hydrochlorothiazide)
  Stada, Germany



• Quinapril / Hydrochloorthiazide PCH (Quinapril and Hydrochlorothiazide)
  Pharmachemie, Netherlands



• Quinapril / Hydrochloorthiazide Sandoz (Quinapril and Hydrochlorothiazide)
  Sandoz, Netherlands



• Quinapril A
  Apothecon, Netherlands



• Quinapril Actavis
  Actavis, Netherlands



• Quinapril AL
  Aliud, Germany; Aliud, Romania



• Quinapril Alternova
  Alternova, Denmark



• Quinapril Apotex Farma
  Tamarang, Spain



• Quinapril Arrow
  Arrow, France



• Quinapril Bexal
  Bexal, Spain



• Quinapril Biogaran
  Biogaran, France



• Quinapril CF
  Centrafarm, Netherlands



• Quinapril Cinfa
  Cinfa, Spain



• Quinapril Cinfamed
  Cinfa, Spain



• Quinapril comp. Heumann (Quinapril and Hydrochlorothiazide)
  Heumann, Germany



• Quinapril EG
  Eurogenerics, Belgium



• Quinapril Generichealth
  Generic Health, Australia



• Quinapril HCT Helvepharm (Quinapril and Hydrochlorothiazide)
  Helvepharm, Switzerland



• Quinapril Helvepharm
  Helvepharm, Switzerland



• Quinapril Hexal
  Hexal, Germany



• Quinapril Hexal comp (Quinapril and Hydrochlorothiazide)
  Hexal, Germany



• Quinapril Hydrochloride and Hydrochlorothiazide (Quinapril and Hydrochlorothiazide)
  Aurobindo, United States; Mylan, United States; Ranbaxy, United States



• Quinapril Hydrochloride
  Actavis, United States; Genpharm, United States; InvaGen, United States; Lupin, United States; Mylan, United States; Ranbaxy, United States; Sandoz, United States; Sun, United States; Teva USA, United States; Torpharm, United States; Watson, United States



• Quinapril Katwijk
  Apotex Europe, Netherlands



• Quinapril Merck
  Merck, Spain; Merck Generics, Italy; Mylan, France; Mylan, Netherlands



• Quinapril MK
  MK, Colombia



• Quinapril Mylan
  Mylan, Belgium



• Quinapril Normon
  Normon, Spain



• Quinapril PCH
  Pharmachemie, Netherlands



• Quinapril Ranbaxy
  Ranbaxy, Spain; Ranbaxy, Netherlands



• Quinapril ratiopharm
  ratiopharm, Netherlands



• Quinapril Sandoz
  Sandoz, Australia; Sandoz, Belgium; Sandoz, Italy; Sandoz, Netherlands



• Quinapril Stada
  Stada, Germany; Stada, Netherlands



• Quinapril Tamarang
  Tamarang, Spain



• Quinapril Teva
  Generics, Slovakia; Teva, Belgium; Teva, Spain; Teva, Italy; Teva Santé, France



• Quinapril Winthrop
  Sanofi-Aventis, France



• Quinapril/Hydrochlorothiazid Alternova (Quinapril and Hydrochlorothiazide)
  Alternova, Sweden



• Quinapril/Hydrochlorothiazide Wyvern (Quinapril and Hydrochlorothiazide)
  Wyvern, France



• Quinapril
  F.G. Ventu, Netherlands; Genéricos Venezolanos, Venezuela; Genéricos RxI.M.G. Rx, Venezuela



• Quinapril-1A Pharma plus (Quinapril and Hydrochlorothiazide)
  1A Pharma, Germany



• Quinapril-DP
  Genepharm, Australia



• Quinapril-HCT Hexal (Quinapril and Hydrochlorothiazide)
  Sandoz, Hungary



• Quinaretic (Quinapril and Hydrochlorothiazide)
  Actavis, United States; Amide, United States



• Quinaspen
  Aspen Pharmacare, South Africa



• Quinazil
  Malesci, Italy



• Quinpres
  Generics, Slovakia



• Quiril
  Sandoz, Switzerland



• Quiril comp. (Quinapril and Hydrochlorothiazide)
  Sandoz, Switzerland



• Qunapril Eg
  EG, Italy



• Quniapril-Teva
  Teva, Czech Republic



• Quprace
  Ranbaxy, Slovakia



• Solpres
  Biotech, Venezuela



• Stadapress (Quinapril and Hydrochlorothiazide)
  Stada, Slovakia

International Drug Name Search

Glossary

BAN	British Approved Name
DCF	Dénomination Commune Française
IS	Inofficial Synonym
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Esperson

Esperson may be available in the countries listed below.

Ingredient matches for Esperson

Desoximetasone

Desoximetasone is reported as an ingredient of Esperson in the following countries:

• Brazil


• Indonesia


• Philippines


• Serbia


• Taiwan

International Drug Name Search

Semecon

Semecon may be available in the countries listed below.

Ingredient matches for Semecon

Simeticone

Simeticone is reported as an ingredient of Semecon in the following countries:

• Bangladesh

International Drug Name Search

Corgard

Corgard is a brand name of nadolol, approved by the FDA in the following formulation(s):

CORGARD (nadolol - tablet; oral)

• 
  Manufacturer: KING PHARMS
  
  Approved Prior to Jan 1, 1982
  
  Strength(s): 40MG ^[AB], 80MG ^[RLD][AB]


• 
  Manufacturer: KING PHARMS
  
  Approval date: October 28, 1986
  
  Strength(s): 20MG ^[AB]

Has a generic version of Corgard been approved?

Yes. The following products are equivalent to Corgard:

nadolol tablet; oral

• 
  Manufacturer: IVAX SUB TEVA PHARMS
  
  Approval date: January 24, 1996
  
  Strength(s): 80MG ^[AB]


• 
  Manufacturer: IVAX SUB TEVA PHARMS
  
  Approval date: August 30, 1996
  
  Strength(s): 20MG ^[AB], 40MG ^[AB]


• 
  Manufacturer: MYLAN
  
  Approval date: October 31, 1993
  
  Strength(s): 20MG ^[AB], 40MG ^[AB], 80MG ^[AB]


• 
  Manufacturer: SANDOZ
  
  Approval date: November 9, 1995
  
  Strength(s): 20MG ^[AB], 40MG ^[AB], 80MG ^[AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Corgard. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Corgard.

See also...

• Corgard Consumer Information (Wolters Kluwer)
• Corgard Consumer Information (Cerner Multum)
• Corgard Advanced Consumer Information (Micromedex)
• Corgard AHFS DI Monographs (ASHP)
• Nadolol Consumer Information (Wolters Kluwer)
• Nadolol Consumer Information (Cerner Multum)
• Alti-Nadolol Advanced Consumer Information (Micromedex)
• Nadolol Advanced Consumer Information (Micromedex)
• Nadolol AHFS DI Monographs (ASHP)

Tropisetron

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

A04AA03

CAS registry number (Chemical Abstracts Service)

0089565-68-4

Chemical Formula

C17-H20-N2-O2

Molecular Weight

284

Therapeutic Categories

Antiemetic

Serotonin antagonist

Chemical Name

1αH,5αH-Tropan-3α-yl indole-3-carboxylate

Foreign Names

• Tropisetronum (Latin)
• Tropisetron (German)
• Tropisétrone (French)
• Tropisetron (Spanish)

Generic Names

• Tropisetron (OS: BAN)
• Tropisétrone (OS: DCF)
• ICS 205930 (IS)
• Tropisetron Hydrochloride (OS: BANM)
• Tropisetron Hydrochloride (PH: Ph. Eur. 6, BP 2010)
• Tropisetroni hydrochloridum (PH: Ph. Eur. 6)

Brand Names

• Navoban
  Novartis, Germany; Novartis, Turkey; Kyowa Hakko Kirin, Japan; Novartis, Argentina; Novartis, Austria; Novartis, Australia; Novartis, Switzerland; Novartis, Chile; Novartis, China; Novartis, Colombia; Novartis, Denmark; Novartis, Estonia; Novartis, Spain; Novartis, Finland; Novartis, France; Novartis, Georgia; Novartis, Greece; Novartis, Hong Kong; Novartis, Croatia (Hrvatska); Novartis, Hungary; Novartis, Indonesia; Novartis, Israel; Novartis, Iceland; Novartis, Italy; Novartis, Japan; Novartis, Lithuania; Novartis, Luxembourg; Novartis, Latvia; Novartis, Mexico; Novartis, Malaysia; Novartis, Norway; Novartis, New Zealand; Novartis, Oman; Novartis, Philippines; Novartis, Poland; Novartis, Portugal; Novartis, Serbia; Novartis, Russian Federation; Novartis, Sweden; Novartis, Slovenia; Novartis, Thailand; Novartis, Taiwan; Novartis, Venezuela; Novartis, South Africa; Novartis Pharmaceuticals, Peru



• Novaban
  Novartis, Belgium; Novartis, Netherlands



• Saronil
  Artis, Spain



• Setrovel
  Novell, Indonesia

International Drug Name Search

Glossary

BAN	British Approved Name
BANM	British Approved Name (Modified)
DCF	Dénomination Commune Française
IS	Inofficial Synonym
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Clobegalen

Clobegalen may be available in the countries listed below.

Ingredient matches for Clobegalen

Clobetasol

Clobetasol 17α-propionate (a derivative of Clobetasol) is reported as an ingredient of Clobegalen in the following countries:

• Germany

International Drug Name Search

Sotalol HCl ratiopharm

Sotalol HCl ratiopharm may be available in the countries listed below.

Ingredient matches for Sotalol HCl ratiopharm

Sotalol

Sotalol hydrochloride (a derivative of Sotalol) is reported as an ingredient of Sotalol HCl ratiopharm in the following countries:

• Netherlands

International Drug Name Search

Silymarin AL

Silymarin AL may be available in the countries listed below.

Ingredient matches for Silymarin AL

Silibinin

Silibinin is reported as an ingredient of Silymarin AL in the following countries:

• Germany

International Drug Name Search

Athlete's Foot

Athlete's Foot may be available in the countries listed below.

Ingredient matches for Athlete's Foot

Tolnaftate

Tolnaftate is reported as an ingredient of Athlete's Foot in the following countries:

• Israel

International Drug Name Search

Selzentry

Selzentry is a brand name of maraviroc, approved by the FDA in the following formulation(s):

SELZENTRY (maraviroc - tablet; oral)

• 
  Manufacturer: VIIV HLTHCARE
  
  Approval date: August 6, 2007
  
  Strength(s): 150MG, 300MG ^[RLD]

Has a generic version of Selzentry been approved?

No. There is currently no therapeutically equivalent version of Selzentry available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Selzentry. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  CCR5 modulators
  Patent 6,586,430
  Issued: July 1, 2003
  Inventor(s): Duncan Robert; Armour & David Anthony; Price & Blanda Luzia Christa; Stammen & Anthony; Wood & Manoussos; Perros & Martin Paul; Edwards
  Assignee(s): Pfizer Inc.
  Compounds of Formula 1 [Region &agr;]-[Region &bgr;]-[Region &ggr;]-[Region &dgr;]  (I) which are useful as modulators of chemokine activity. The invention also provides pharmaceutical formulations and methods of treatment using these compounds.
  
  Patent expiration dates:
  
  
  • December 1, 2019
    
    ✓ 
    Patent use: METHOD OF TREATING PATIENTS INFECTED WITH CCR5-TROPIC HIV-1
    ✓ 
    Drug substance
    ✓ 
    Drug product
  
  



• 
  Tropane derivatives useful in therapy
  Patent 6,667,314
  Issued: December 23, 2003
  Inventor(s): Manoussos; Perros & David Anthony; Price & Blanda Luzia Christa; Stammen & Anthony; Wood
  Assignee(s): Pfizer, Inc.
  The present invention provides compounds of the formula: wherein R1 is C3-6 cycloalkyl optionally substituted by one or more fluorine atoms, or C1-6 alkyl optionally substituted by one or more fluorine atoms, or C3-6 cycloalkylmethyl optionally ring-substituted by one or more fluorine atoms; and R2 is phenyl optionally substituted by one or more fluorine atoms, to pharmaceutically acceptable salts and solvates thereof, and to processes for the preparation of, intermediates used in the preparation of, compositions containing and the uses of, such compounds.
  
  Patent expiration dates:
  
  
  • August 6, 2021
    
    ✓ 
    Patent use: METHOD OF TREATING PATIENTS INFECTED WITH CCR5-TROPIC HIV-1
    ✓ 
    Drug substance
    ✓ 
    Drug product
  
  



• 
  Tropane derivatives useful in therapy
  Patent 7,368,460
  Issued: May 6, 2008
  Inventor(s): Perros; Manoussos & Price; David Anthony & Stammen; Blanda Luzia Christa & Wood; Anthony
  Assignee(s): Pfizer, Inc.
  The present invention provides compounds of the formula: wherein R1 is C3-6 cycloalkyl optionally substituted by one or more fluorine atoms, or C1-6 alkyl optionally substituted by one or more fluorine atoms, or C3-6 cycloalkylmethyl optionally ring-substituted by one or more fluorine atoms; and R2 is phenyl optionally substituted by one or more fluorine atoms, to pharmaceutically acceptable salts and solvates thereof, and to processes for the preparation of, intermediates used in the preparation of, compositions containing and the uses of, such compounds.
  
  Patent expiration dates:
  
  
  • November 25, 2022
    
    ✓ 
    Patent use: METHOD OF TREATING PATIENTS INFECTED WITH CCR5-TROPIC HIV-1
  
  



• 
  Tropane derivatives useful in therapy
  Patent 7,576,097
  Issued: August 18, 2009
  Inventor(s): Perros; Manoussos & Price; David Anthony & Stammen; Blanda Luzia Christa & Wood; Anthony
  Assignee(s): Pfizer, Inc.
  The present invention provides compounds of the formula: wherein R1 is C3-6 cycloalkyl optionally substituted by one or more fluorine atoms, or C1-6 alkyl optionally substituted by one or more fluorine atoms, or C3-6 cycloalkylmethyl optionally ring-substituted by one or more fluorine atoms; and R2 is phenyl optionally substituted by one or more fluorine atoms, to pharmaceutically acceptable salts and solvates thereof, and to processes for the preparation of, intermediates used in the preparation of, compositions containing and the uses of, such compounds.
  
  Patent expiration dates:
  
  
  • May 25, 2021
    
    ✓ 
    Drug substance
  
  

Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

• Exclusivity expiration dates:
  • August 6, 2012 - NEW CHEMICAL ENTITY
  
  
  • May 28, 2013 - NEW PATIENT POPULATION
  
  

See also...

• Selzentry Consumer Information (Drugs.com)
• Selzentry Consumer Information (Wolters Kluwer)
• Selzentry Consumer Information (Cerner Multum)
• Selzentry Advanced Consumer Information (Micromedex)
• Selzentry AHFS DI Monographs (ASHP)
• Maraviroc Consumer Information (Wolters Kluwer)
• Maraviroc Consumer Information (Cerner Multum)
• Maraviroc Advanced Consumer Information (Micromedex)
• Maraviroc AHFS DI Monographs (ASHP)